The vasodilatory activity of CGRP: a response.
作者信息
Bigal Marcelo E, Walter Sarah, Rapoport Alan M
机构信息
Labrys Biologics, Doylestown, PA, USA.
出版信息
Headache. 2014 Apr;54(4):748-9. doi: 10.1111/head.12316.
PMID:24697226
Abstract
摘要
相似文献
1
The vasodilatory activity of CGRP: a response.降钙素基因相关肽的血管舒张活性：一种反应。
Headache. 2014 Apr;54(4):748-9. doi: 10.1111/head.12316.
2
Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.降钙素基因相关肽 (CGRP) 与偏头痛：当前认识和研发状况。
Headache. 2013 Sep;53(8):1230-44. doi: 10.1111/head.12179. Epub 2013 Jul 12.
3
Patent watch: Migraine therapies targeting the CGRP pathway: intellectual property landscape.专利观察：针对降钙素基因相关肽（CGRP）通路的偏头痛疗法：知识产权格局
Nat Rev Drug Discov. 2016 Jan;15(1):8-9. doi: 10.1038/nrd.2015.11. Epub 2015 Dec 16.
4
Therapeutic antibodies against CGRP or its receptor.针对降钙素基因相关肽（CGRP）或其受体的治疗性抗体。
Br J Clin Pharmacol. 2015 Jun;79(6):886-95. doi: 10.1111/bcp.12591.
5
Calcitonin gene-related peptide (CGRP) antagonists and migraine: is this a new era?降钙素基因相关肽（CGRP）拮抗剂与偏头痛：这是一个新时代吗？
Neurology. 2008 Apr 15;70(16):1300-1. doi: 10.1212/01.wnl.0000309214.25038.fd.
6
Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.聚焦偏头痛的抗 CGRP 单克隆抗体：迄今为止的临床证据。
Clin Pharmacol Drug Dev. 2017 Nov;6(6):534-547. doi: 10.1002/cpdd.345. Epub 2017 Apr 14.
7
CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine.降钙素基因相关肽与偏头痛：阻断降钙素基因相关肽配体和受体在偏头痛治疗中的作用。
Drugs. 2018 Jun;78(9):913-928. doi: 10.1007/s40265-018-0923-5.
8
Targeting calcitonin gene-related peptide: a new era in migraine therapy.针对降钙素基因相关肽：偏头痛治疗的新时代。
Lancet. 2019 Nov 9;394(10210):1765-1774. doi: 10.1016/S0140-6736(19)32504-8. Epub 2019 Oct 23.
9
Emerging Treatments in Episodic Migraine.发作性偏头痛的新兴治疗方法。
Curr Pain Headache Rep. 2018 Jul 16;22(9):61. doi: 10.1007/s11916-018-0716-2.
10
Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment.降钙素基因相关肽（受体）抗体：偏头痛治疗的新途径。
Genome Med. 2018 Feb 22;10(1):10. doi: 10.1186/s13073-018-0524-7.
引用本文的文献
1
Targeting CGRP: A New Era for Migraine Treatment.靶向降钙素基因相关肽：偏头痛治疗的新时代。
CNS Drugs. 2015 Jun;29(6):443-52. doi: 10.1007/s40263-015-0253-z.
2
TEV-48125: a review of a monoclonal CGRP antibody in development for the preventive treatment of migraine.TEV-48125：一种用于偏头痛预防性治疗的正在研发的单克隆降钙素基因相关肽（CGRP）抗体的综述
Curr Pain Headache Rep. 2015 Mar;19(3):6. doi: 10.1007/s11916-015-0476-1.
Zotero 插件